Instrumento Inactivo

Otros idiomas Skyline Medical Inc Nasdaq

Acciones

US83084T3095

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

15/05	Transcript : Predictive Oncology Inc., Q1 2024 Earnings Call, May 15, 2024
01/05	Wall Street abrirá a la baja a la espera de la decisión de la Fed sobre los tipos; las cifras de empleo privado superan las previsiones	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q1 Revenue $419,646	15/05
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update	15/05
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024	13/05
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024	10/05
Predictive Oncology : Material Agreement - Form 8-K	06/05
Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts	01/05
Investors Await Fed Rate Decision as US Futures Trend Lower in Wednesday's Premarket	01/05
Top Premarket Gainers	01/05
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine	30/04
Predictive Oncology Inc. Announces Significant Progress with FluGen in Development of Intranasal Flu Vaccine	30/04
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting	25/04
FUJIFILM Wako Chemicals U.S.A. Corporation and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals	25/04
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update	28/03
Predictive Oncology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Predictive Oncology to Participate in Upcoming Investor Conferences	21/02
Predictive Oncology Inc. Announces Resignation of Pamela Bush, as Chief Business Officer, Effective from February 15, 2024	08/02
Predictive Oncology to Participate in Upcoming San Francisco Conferences	02/01
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q3 Revenue $715,056	14/11
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update	14/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Skyline Medical Inc Nasdaq

Acciones

US83084T3095

Otros idiomas

Filtros